HealthDay - TUESDAY, Jan. 15 (HealthDay News) -- Treatment that combines themonoclonal antibody rituximab with six cycles of chemotherapy improvessurvival in elderly patients with aggressive lymphoma, German doctorsreport.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.